Keywords: positive, data, ph, iii, study, roche, bonviva/boniva

Positive data from Ph III study of Roche's Bonviva/Boniva

Article | 12 July 2004

Print This

Swiss drug major Roche has reported positive results from the first yearof a Phase III study, known as DIVA (Dosing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in